Search clinical trials for: bimatoprost 0.01%
Total 2138 results
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedLong-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionOcular Hypertension | GlaucomaSpain, France, Belgium, Israel, United Kingdom, Poland, Italy, Czechia, Germany, Hungary
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleKorea, Republic of
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Primary Open AngleTaiwan
-
Eisai LimitedCompleted
-
University of California, San DiegoCompletedOcular Hypertension | Glaucoma | Intraocular PressureUnited States
-
Laboratoires TheaCompletedPrimary Open Angle Glaucoma | Ocular HypertensionFrance
-
Northwestern UniversityAllerganCompletedIntraocular Pressure | Nail Growth CessationUnited States
-
AllerganCompletedEyelash HypotrichosisUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleNetherlands
-
AllerganCompletedA Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)Ocular Hypertension | Glaucoma, Open-AngleGermany
-
Amneal Pharmaceuticals, LLCCBCC Global Inc.; Amneal EU, LimitedNot yet recruitingOcular Hypertension | Open-angle GlaucomaUnited States
-
Amneal Pharmaceuticals, LLCCBCC Global ResearchRecruitingOcular Hypertension | Glaucoma, Open-AngleUnited States
-
Mankind Pharma LimitedCBCC Global ResearchCompleted
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleAustria
-
AllerganCompletedOcular Hypertension | Glaucoma, Primary Open AngleCanada
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleSwitzerland
-
AllerganCompletedIdiopathic Eyelash HypotrichosisRussian Federation, Sweden, United States, United Kingdom
-
SCAI TherapeuticsCompletedDry Eye SyndromesKorea, Republic of
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
AllerganCompletedMeibomian Gland DysfunctionUnited States
-
Universitaire Ziekenhuizen KU LeuvenAllerganUnknownOcular Hypertension | GlaucomaBelgium, Austria, Italy, Switzerland, United Kingdom
-
PfizerCompletedPlaque Psoriasis | Atopic DermatitisUnited States, Canada, United Kingdom, Japan
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleChina
-
AllerganCompletedEyelash HypotrichosisUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleChina
-
AllerganCompletedEyelash HypotrichosisKorea, Republic of
-
Indiana University School of MedicineCompleted
-
Singapore National Eye CentreAllerganUnknownGlaucoma, Angle-ClosureSingapore
-
AllerganCompletedEyelash HypotrichosisJapan
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Open-Angle GlaucomaBelgium
-
AllerganCompletedEyelash HypotrichosisJapan
-
Innovative MedicalCompleted
-
Rabin Medical CenterCompletedThyroid Associated OphthalmopathiesIsrael
-
Cairo UniversityCompleted
-
AllerganCompletedOcular Hypertension | Open-Angle GlaucomaUnited States, Israel, Canada, Singapore, Philippines, Spain, Australia, Belgium, Brazil, Germany
-
AllerganCompletedHypotrichosisUnited States
-
Innovative MedicalCompletedGlaucomaUnited States
-
Spirig Pharma Ltd.CompletedActinic KeratosisSwitzerland, Germany
-
AllerganCompletedHypotrichosisUnited States, United Kingdom
-
AllerganCompleted
-
Tulane UniversityAllerganCompleted
-
Gian Sagar Medical College and HospitalWithdrawnVitiligo | Repigmentation
-
Utrecht Institute for Pharmaceutical SciencesCompleted
-
AllerganCompletedEyelashesUnited States, Canada
-
Alcon ResearchCompletedOcular Hypertension | Glaucoma